Stock Market News

Lexicon Pharma (LXRX), Novo Nordisk (NVO) Initiate Phase 1 Study for Obesity Drug LX9851

wccwcc
May 2, 2026 - 11:00
 0  1
Lexicon Pharma (LXRX), Novo Nordisk (NVO) Initiate Phase 1 Study for Obesity Drug LX9851

What's Your Reaction?

like like 0
dislike dislike 0
love love 0
funny funny 0
angry angry 0
sad sad 0
wow wow 0
wcc
wcc

Related Posts

Trump's name must be removed from Kennedy Center, judge rules

Trump's name must be removed from Kennedy Center, judge...

wcc May 30, 2026  0  0

Michael Dell courted Trump early. His company has reaped rewards

Michael Dell courted Trump early. His company has reape...

wcc May 30, 2026  0  0

Mercedes-Benz may be shut out of U.S. market under bill aimed at Chinese automaker ownership

Mercedes-Benz may be shut out of U.S. market under bill...

wcc May 30, 2026  0  0

IRS unveils new health savings account limits for 2027

IRS unveils new health savings account limits for 2027

wcc May 30, 2026  0  0

Postal Service proposes requiring states to provide mail-in ballot voter lists

Postal Service proposes requiring states to provide mai...

wcc May 30, 2026  0  1

Iran war cost: Average U.S. household paying $450 more on gas and energy

Iran war cost: Average U.S. household paying $450 more ...

wcc May 30, 2026  0  1